Trial intelligence / Profile preview

Ramipril Effect on Muscle Gene Expression in Healthy Subjects

NCT00657865Phase 4Completed

Sponsor
Medical University of Vienna
Start
Mar 2008
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ramipril in type 2 diabetes mellitus (T2DM), metabolic syndrome, sponsored by Medical University of Vienna. Started Mar 2008; status: completed.

02

Drugs

ramipril
03

Conditions

type 2 diabetes mellitus (T2DM)metabolic syndrome

Beyond the preview

Go deeper on NCT00657865.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00657865.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call